Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
- Phio Pharmaceuticals Corp. approved a reverse stock split at a ratio of 1-for-9. - The reverse stock split aims to increase the per share trading price. - Number of outstanding common stock shares will decrease significantly post-split. - Company's transfer agent will handle the exchange process for stockholders. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Corporate Developments
- Phio Pharmaceuticals Corp. approved a reverse stock split at a ratio of 1-for-9.
- The reverse stock split aims to increase the per share trading price.
- Number of outstanding common stock shares will decrease significantly post-split.
- Company's transfer agent will handle the exchange process for stockholders.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.